October 22, 2009 (Atlanta, Georgia) — An oral contraceptive (OC) consisting of estradiol valerate/dienogest (E2V/DNG) appears to be effective in resolving abnormal menstrual symptoms in patients ...
e2v’s directors have unanimously recommended that e2v Shareholders vote in favor of the Offer. In addition, Teledyne has received irrevocable undertakings from e2v directors and irrevocable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results